May 7 |
Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
|
May 7 |
Vanda Pharmaceuticals up 15% as Future Pak sweetens bid
|
May 7 |
UPDATE 2-Future Pak sweetens take-private offer for Vanda Pharmaceuticals
|
Apr 30 |
Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024
|
Apr 25 |
UPDATE 1-Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer
|
Apr 25 |
Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
|
Apr 24 |
Vanda Pharmaceuticals (VNDA) Stock Sinks As Market Gains: What You Should Know
|
Apr 24 |
Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
|
Apr 22 |
Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZĀ® ANDA Litigation
|
Apr 22 |
US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz
|